← Eichor
Condition: Mitochondrial Encephalopathy Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Mitochondrial Encephalopathy

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

The NIH MINI Study: Metabolism, Infection, and Immunity in Inborn Errors of Metabolism
Phase N/A · 1 location(s) · National Human Genome Research Institute (NHGRI) · NCT01780168
Deoxynucleosides Pyrimidines as Treatment for Mitochondrial Depletion Syndrome
Phase 2 · 1 location(s) · Kenneth Myers, MD · NCT04802707
The International Registry for Leigh Syndrome
Phase N/A · 1 location(s) · The University of Texas Health Science Center, Houston · NCT03137355
North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)
Phase N/A · 17 location(s) · Columbia University · NCT01694940
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Phase N/A · 2 location(s) · Sanford Health · NCT01793168
The Natural History Study of Mitochondrial NeuroGastroIntestinal Encephalopathy (MNGIE)
Phase N/A · 1 location(s) · Columbia University · NCT01694953
Systemic Biomarkers of Brain Injury From Hyperammonemia
Phase N/A · 1 location(s) · Children's National Research Institute · NCT04602325
Natural History Study of Patients with HPDL Mutations
Phase N/A · 1 location(s) · University of California, San Diego · NCT05848271
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.